Leaked FDA Memo: Child Deaths Linked to Vaccines?

A healthcare professional preparing a syringe from a vial

A leaked Food and Drug Administration staff memo linking at least 10 children’s deaths to COVID-19 vaccines—followed by months of institutional silence and pushback—raises urgent questions about transparency, accountability, and parental consent.

Story Snapshot

FDA staff memo said “no fewer than” 10 child deaths were linked to COVID-19 vaccination [1][6].
Report cited myocarditis and reanalyzed Vaccine Adverse Event Reporting System records as the basis [5].
Twelve former FDA commissioners and current staff criticized the claim for lacking evidence and detail [2][5].
FDA already mandates myocarditis warnings for mRNA vaccines, highest in males 12–24 [7].

What the FDA Memo Claimed and Why It Matters

Public reporting states an internal Food and Drug Administration memo dated November 28 asserted “no fewer than” 10 children died due to COVID-19 vaccination, with myocarditis implicated as the mechanism [1][6]. Coverage says the memo was attributed to a senior vaccines official, with summaries in major outlets describing a review that connected the deaths to vaccination but without releasing supporting records to the public [3][4]. The claim marks the first time such deaths were reportedly acknowledged in an internal Food and Drug Administration document [6].

Reports indicate the assertion relied on reanalysis of adverse event submissions in the federal Vaccine Adverse Event Reporting System, which collects post‑vaccination reports from any source [5]. Critics emphasized that Vaccine Adverse Event Reporting System entries are unverified and designed to generate safety signals rather than prove causation [2]. Analysts further noted the memo did not include the children’s ages, comorbidities, or methodological details for determining cause of death, limiting independent evaluation [1][5].

Pushback From Former FDA Leaders and Data Gaps

Reaction from within and outside the Food and Drug Administration quickly challenged the memo’s conclusions. Twelve former Food and Drug Administration commissioners and current staff criticized the claim, arguing that sweeping safety judgments require publicly available evidence and clear methods, not summaries of unverified reports [2][5]. Commentaries underscored that Vaccine Adverse Event Reporting System submissions alone cannot establish causality and warned that framing them as proof risks confusing parents and undermining trust without rigorous data [2][5].

Coverage also noted the absence of vital specifics. Reports say the memo lacked case-level information, autopsy findings, or criteria used to adjudicate vaccine causality, and it did not reference a peer‑reviewed analysis [1][5]. Without transparent data on timing, pathology, or confounders, independent experts cannot test the conclusion. That information gap has fueled polarized debate, with some amplifying the claim beyond the stated 10 cases and others dismissing any safety signal outright—neither response grounded in verified evidence [1].

What We Do Know: Myocarditis Warnings and Labeling

The Food and Drug Administration has updated required labeling for the authorized mRNA vaccines to warn about myocarditis and pericarditis, with observed risk highest in males aged 12 through 24 years [7]. The labeling action acknowledges a real, though rare, adverse event profile, and it directs clinicians and families to monitor symptoms and weigh benefits and risks. That established warning provides an important factual anchor while debates about unpublicized case reviews continue [7].

Oh SHYT‼️

🚨 FDA chief Marty Makary is Resigning!

Just last month, Dr. Robert Malone said Marty Makary is the person responsible for HIDING COVID-19 Vaccine Pediatric Deaths from the public. And today he resigns. 👀 pic.twitter.com/O3lIfLBDg9

— Joe Rogan (@roganw40) May 13, 2026

For parents, two truths must be held together. First, the existence of myocarditis risk is already recognized in official labeling for young males [7]. Second, the specific claim of 10 vaccine‑caused child deaths remains opaque without case details, independent verification, and publication of methods [1][5]. Responsible policy requires the Food and Drug Administration to release the memo’s underlying records, criteria, and adjudications so the public, clinicians, and researchers can evaluate the evidence directly rather than rely on secondhand summaries [1][5].

Accountability Steps the Public Deserves Now

Congressional overseers and the Department of Health and Human Services inspector general should secure a complete case‑level release of the internal review, including age ranges, medical histories, diagnostic timelines, autopsy reports, and how causality was determined from Vaccine Adverse Event Reporting System inputs [1][5]. Manufacturers and the Food and Drug Administration should also expedite and publish required follow‑up on myocarditis outcomes in adolescents and young adults, with open data for independent analysis, to ensure parents get clear, consistent guidance grounded in evidence rather than bureaucratic filters [7].